DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy

Sleep Medicine

Volumn 13, Issue 6, 2012, Pages 736-742

  Menzler, K ^a   Belke, M ^a   Unger, M M ^a   Ohletz, T ^a   Keil, B ^a   Heverhagen, J T ^a   Rosenow, F ^a   Mayer, G ^b   Oertel, W H ^a   Moller J C ^a   Knake, S ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Hephata Clinic for Neurology   (Germany)

Author keywords

Hypocretin; Hypothalamus; Medulla oblongata; Mesencephalon; MRI; Pons; Sleep

Indexed keywords

ADULT; ARTICLE; BRAIN MICROSTRUCTURE; BRAIN REGION; BRAIN STEM; CAPSULA INTERNA; CAUDATE NUCLEUS; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORONA RADIATA (BRAIN); DIFFUSION TENSOR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; MESENCEPHALON; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; POSTCENTRAL GYRUS; PRIMARY MOTOR CORTEX; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TEMPORAL LOBE; WHITE MATTER LESION;

ADULT; BRAIN STEM; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; HYPOTHALAMUS; LEUKOENCEPHALOPATHIES; MALE; MEDULLA OBLONGATA; MESENCEPHALON; MIDDLE AGED; NARCOLEPSY; NERVE FIBERS, MYELINATED; PONS; TEMPORAL LOBE;

EID: 84861930619     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2012.02.013     Document Type: Article

References (41)

1. Overeem S., Mignot E., van Dijk J.G., Lammers G.J. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol 2001, 18:78-105.
2. Danker-Hopfe H., Binder R., Popp R., Sauter C., Büttner A., Böhning W., et al. Assessment of the implementation of the Multiple Sleep Latency Test (MSLT) in Acredited Sleep Labd. Somnologie 2006, 10:43-52.
3. Rivera V.M., Meyer J.S., Hata T., Ishikawa Y., Imai A. Narcolepsy following cerebral hypoxic ischemia. Ann Neurol 1986, 19:505-508.
4. Aldrich M.S., Naylor M.W. Narcolepsy associated with lesions of the diencephalon. Neurology 1989, 39:1505-1508.
5. D'Cruz O.F., Vaughn B.V., Gold S.H., Greenwood R.S. Symptomatic cataplexy in pontomedullary lesions. Neurology 1994, 44:2189-2191.
6. Fernandez J.M., Sadaba F., Villaverde F.J., Alvaro L.C., Cortina C. Cataplexy associated with midbrain lesion. Neurology 1995, 45:393-394.
7. Plazzi G., Montagna P., Provini F., Bizzi A., Cohen M., Lugaresi E. Pontine lesions in idiopathic narcolepsy. Neurology 1996, 46:1250-1254.
8. Frey J.L., Heiserman J.E. Absence of pontine lesions in narcolepsy. Neurology 1997, 48:1097-1099.
9. Kaufmann C., Schuld A., Pollmacher T., Auer D.P. Reduced cortical gray matter in narcolepsy: preliminary findings with voxel-based morphometry. Neurology 2002, 58:1852-1855.
10. Brenneis C., Brandauer E., Frauscher B., Schocke M., Trieb T., Poewe W., et al. Voxel-based morphometry in narcolepsy. Sleep Med 2005, 6:531-536.
11. Overeem S., Steens S.C., Good C.D., Ferrari M.D., Mignot E., Frackowiak R.S., et al. Voxel-based morphometry in hypocretin-deficient narcolepsy. Sleep 2003, 26:44-46.
12. Erlich S.S., Itabashi H.H. Narcolepsy: a neuropathologic study. Sleep 1986, 9:126-132.
13. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999, 98:365-376.
14. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000, 27:469-474.
15. Arias-Carrion O., Drucker-Colin R., Murillo-Rodriguez E. Survival rates through time of hypocretin grafted neurons within their projection site. Neurosci Lett 2006, 404:93-97.
16. Nishino S., Ripley B., Overeem S., Lammers G.J., Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000, 355:39-40.
17. Draganski B., Geisler P., Hajak G., Schuierer G., Bogdahn U., Winkler J., et al. Hypothalamic gray matter changes in narcoleptic patients. Nat Med 2002, 8:1186-1188.
18. Joo E.Y., Tae W.S., Kim S.T., Hong S.B. Gray matter concentration abnormality in brains of narcolepsy patients. Korean J Radiol 2009, 10:552-558.
19. Salat D.H., Tuch D.S., van der Kouwe A.J., Greve D.N., Pappu V., Lee S.Y., et al. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging 2008, 31:244-256.
20. Knake S., Belke M., Menzler K., Pilatus U., Eggert K.M., Oertel W.H., et al. In vivo demonstration of microstructural brain pathology in progressive supranuclear palsy: a DTI study using TBSS. Mov Disord 2010, 25:1232-1238.
21. Unger M.M., Belke M., Menzler K., Heverhagen J., Keil B., Stiasny-Kolster K., et al. Diffusion tensor imaging in idiopathic REM sleep behaviour disorder (iRBD) reveals microstructural changes in the brainstem, the olfactory cortex and other brain regions. Sleep 2010, 33:767-773.
22. Pierpaoli C., Basser P.J. Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996, 36:893-906.
23. American Academy of Sleep Medicine. International classification of sleep disorders. In: Diagnostic and coding manual. Westchester, IL: 2005.
24. Menzler K., Belke M., Wehrmann E., Krakow K., Lengler U., Jansen A., et al. Men and women are different: diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum. Neuroimage 2011, 54:2557-2562.
25. Basser P.J. New histological and physiological stains derived from diffusion-tensor MR images. Ann N Y Acad Sci 1997, 820:123-138.
26. Joo E.Y., Tae W.S., Kim J.H., Kim B.T., Hong S.B. Glucose hypometabolism of hypothalamus and thalamus in narcolepsy. Ann Neurol 2004, 56:437-440.
27. Dauvilliers Y., Comte F., Bayard S., Carlander B., Zanca M., Touchon J. A brain PET study in patients with narcolepsy-cataplexy. J Neurol Neurosurg Psychiatry 2010, 81:344-348.
28. Dang-Vu T.T., Desseilles M., Petit D., Mazza S., Montplaisir J., Maquet P. Neuroimaging in sleep medicine. Sleep Med 2007, 8:349-372.
29. Pullicino P., Ostrow P., Miller L., Snyder W., Munschauer F. Pontine ischemic rarefaction. Ann Neurol 1995, 37:460-466.
30. McCarley R.W., Hobson J.A. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 1975, 189:58-60.
31. Boeve B.F., Silber M.H., Saper C.B., Ferman T.J., Dickson D.W., Parisi J.E., et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007, 130:2770-2788.
32. Lu J., Sherman D., Devor M., Saper C.B. A putative flip-flop switch for control of REM sleep. Nature 2006, 441:589-594.
33. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998, 18:9996-10015.
34. Saper C.B., Scammell T.E., Lu J. Hypothalamic regulation of sleep and circadian rhythms. Nature 2005, 437:1257-1263.
35. Hishikawa Y., Shimizu T. Physiology of REM sleep, cataplexy, and sleep paralysis. Adv Neurol 1995, 67:245-271.
36. Joo E.Y., Hong S.B., Tae W.S., Kim J.H., Han S.J., Cho Y.W., et al. Cerebral perfusion abnormality in narcolepsy with cataplexy. Neuroimage 2005, 28:410-416.
37. Eisensehr I., Linke R., Tatsch K., von Lindeiner H., Kharraz B., Gildehaus F.J., et al. Alteration of the striatal dopaminergic system in human narcolepsy. Neurology 2003, 60:1817-1819.
38. 123I]IBZM SPET analysis of dopamine D2 receptor occupancy in narcoleptic patients in the course of treatment. Biol Psychiatry 1996, 39:107-111.
39. MacFarlane J.G., List S.J., Moldofsky H., Firnau G., Chen J.J., Szechtman H., et al. Dopamine D2 receptors quantified in vivo in human narcolepsy. Biol Psychiatry 1997, 41:305-310.
40. Alexander A.L., Lee J.E., Lazar M., Field A.S. Diffusion tensor imaging of the brain. Neurotherapeutics 2007, 4:316-329.
41. Salat D.H., Tuch D.S., Hevelone N.D., Fischl B., Corkin S., Rosas H.D., et al. Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci 2005, 1064:37-49.